Evidence and Information for Policy The World Health Survey Health System Metrics Glion, 28-29 September 2006.

Slides:



Advertisements
Similar presentations
Measurement and Health Information WHO Health Surveys Calverton, Maryland, July 2007 Somnath Chatterji Measurement and Health Information Systems.
Advertisements

___________________________________________________________________________________ Health System Metrics Technical Meeting, September 28-29, Glion.
Better Financing for Better HealthEvidence and Information for Policy (EIP) David B Evans Department of Health Systems Financing (HSF) Health System Metrics.
WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Diphtheria Incidence in the WHO European Region 1990 Source; WHO/UNICEF.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
Vaccine in National Immunization Programme Update March 2015.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
World Health Organization
TITLE from VIEW and SLIDE MASTER | August 7, |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *
WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
World Health Organization
Georgian Health Care 2020 Washington DC, February 1-2, 2010
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
HSA 171 CAR. 1436/ 7/4  The results of activities of an organization or investment over a given period of time.  Organizational Performance: ◦ A measure.
Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.
DOTS Expansion: Monitoring Drugs Leopold Blanc TBS, Stop TB WHO, Communicable Diseases.
Evidence and Information for Policy Christopher J.L. Murray Executive Director Evidence and Information for Policy World Health Organization National Capacity.
World Health Assembly 63 Geneva, Suisse May 2010 WORLD HEALTH EDITORS NETWORK Tracking Global Health News: building health literacy Multi-Drug Resistant.
Global Programme on Evidence for Health Policy Presentation by the Epidemiology and Burden of Disease Team of the World Health Organization at the United.
Re-thinking a roadmap to pursue Universal Health Coverage in Palestine – a discourse Awad MATARIA, PhD Health Economist World Health Organization – Eastern-Mediterranean.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 21.
Insurance as a Sub-Function of Finance. Relations between functions and objectives of a health system Stewardship (oversight) Financing (collecting, pooling.
The changing vaccination landscape and the sources of vaccination data
Global Programme on Evidence for Health Policy Mapping Poverty: Predicting Income using the LandScan Database Workshop on Gridding Population Data CIESIN,
Strategic Information and the Control of Tuberculosis Brian Williams and Chris Dye TB programme, Monitoring and Evaluation, WHO.
WHO and International Panel International Collaborative Effort on Injury Statistics Hyatt Regency, Washington September 7-8, 2006.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Health Systems 16/12
Catastrophic health expenditure Webinar PBF and Equity – 21 June 2012 Catherine Korachais, Public Health Dept, Institute of Tropical Medicine, Antwerp,
Global Programme on Evidence for Health Policy The use of GIS in the Global Programme on Evidence for Health Policy (GPE) Meeting on Cartography and Geographic.
Vaccine in National Immunization Programme Update April 2016.
NATIONAL HEALTH INSURANCE 14 th October 2016 Dr Anban Pillay 1.
World Health Organization
Measuring Progress Toward UHC
SAGE 2010 Sampling Distribution
WHO The World Health Survey General Introduction
financial requirements
reporting rate of discarded cases* per 100'000 population**
Ageing Matters Somnath Chatterji Information, Evidence and Research
Alarcos Cieza, MSc, MPH, PhD Coordinator Disability and Rehabilitation
World Health Organization
Monthly Distribution of Wild Poliovirus Cases1,
SAGE 2009 Sampling Distribution
Countries Having Introduced Hib Vaccine
Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010
Sampling Distribution
Non-polio AFP Rate July 2014 – June 2015 July 2015 – June 2016
Monthly Distribution of Wild Poliovirus Cases1,
(70 countries or 36%) (23 countries or 12%)
Countries with Genotype data available
Countries Using Hib Vaccine in National Immunization Schedule in 2010 and Countries Approved for GAVI Support for Use from 2011 Onwards Yes (166 countries.
World Health Organization
Advancing Partnerships for Universal Health Coverage
Onset of most recent WPV1 Case Number of WPV infected districts
Countries having introduced HepB vaccine
Mapping Levels of Palliative Care Development: A Global Update
Countries Using Mening Vaccine in National Immunization Schedule 2011
- Use same categories as for bar chart below Introduced Without GAVI
Onset of most recent case Number of infected districts
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.
National Health Policy and Strategic Shifts
2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)
World Health Organization
World Health Organization
Presentation transcript:

Evidence and Information for Policy The World Health Survey Health System Metrics Glion, September 2006

Evidence and Information for Policy Q uestions raised by policy makers How well is our health system doing? How do we know if we are making progress? How well are we doing given the resources? Where are the main problems? What can and should be fixed? What will it cost? What is the best use of limited (additional) resources? How well is our health system doing? How do we know if we are making progress? How well are we doing given the resources? Where are the main problems? What can and should be fixed? What will it cost? What is the best use of limited (additional) resources?

Evidence and Information for Policy Goals of Health Systems Performance Assessment Provide national decision-makers and the public with sound evidence:  to inform strategic decisions on health sector reform and health system organization e.g. financing arrangements, regulation of private providers  to inform implementation of programmes by local, regional and national managers  to monitor progress towards national targets for health and health systems Provide national decision-makers and the public with sound evidence:  to inform strategic decisions on health sector reform and health system organization e.g. financing arrangements, regulation of private providers  to inform implementation of programmes by local, regional and national managers  to monitor progress towards national targets for health and health systems

Evidence and Information for Policy Stewardship (oversight) Financing (collecting, pooling and purchasing) FUNCTIONS THE SYSTEM PERFORMS GOALS / OUTCOMES OF THE SYSTEM Health Fair financial contribution Responsiveness (to people’s non medical expectations) Creating resources (investment and training) Delivering services (provision) The WHO health system framework INPUTSINPUTS Coverage Provider Performance

Evidence and Information for Policy The World Health Survey Objectives develop a low cost means of providing data  that is valid, relevant, reliable and comparable  on outcomes, functions & inputs to health systems  to supplement the information provided by HIS

Evidence and Information for Policy The World Health Survey Objectives build the evidence base necessary for policy-makers  to routinely monitor if health systems are achieving the desired goals  and in some countries, to assess if the increase in health resources is having the desired effect

Evidence and Information for Policy World Health Survey 71 SURVEYS in 71 countries Household - long : 53 Household - short: 14 CATI : 4 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved

Evidence and Information for Policy World Health Survey Content 1. Health Expenditure and Economic status 2. Measurement of Health States 3. Risk Factors 4. Mortality 5. Coverage 6. Responsiveness 7. Health System Goals 1. Health Expenditure and Economic status 2. Measurement of Health States 3. Risk Factors 4. Mortality 5. Coverage 6. Responsiveness 7. Health System Goals

Evidence and Information for Policy  Information on health care spending  Provides reliable figures for health care fraction of household expenditure  Provides an alternative way of estimating or validating permanent income data  Information on health care spending  Provides reliable figures for health care fraction of household expenditure  Provides an alternative way of estimating or validating permanent income data World Health Survey Household Health Expenditure

Evidence and Information for Policy  protection from catastrophic health expenditure  access to health services  reduction of financial burden of paying for health services  protection from catastrophic health expenditure  access to health services  reduction of financial burden of paying for health services World Health Survey Health Insurance

Evidence and Information for Policy Baseline data on national healthy life expectancies and inequalities in healthy life expectancies in absolute terms and by income groups Health is a multidimensional experience Difficulty in 8 domains of functioning based on an international framework Valuation of health states to combine measurement across domains Baseline data on national healthy life expectancies and inequalities in healthy life expectancies in absolute terms and by income groups Health is a multidimensional experience Difficulty in 8 domains of functioning based on an international framework Valuation of health states to combine measurement across domains Health State Description World Health Survey Health State Description

Evidence and Information for Policy World Health SurveyCoverage Do those with health care needs get the necessary health interventions?  DETERMINANTS: What determines the coverage ?  BARRIERS: What are the barriers preventing coverage ?

Evidence and Information for Policy Catastrophic expenditure and impoverishment

Evidence and Information for Policy Out of pocket payment

Evidence and Information for Policy Coverage

Evidence and Information for Policy Coverage

Evidence and Information for Policy Responsiveness problems communicating

Evidence and Information for Policy World Health Survey Future steps Strengthen Health Information Systems by  Supplementing vital registration systems  Combining census, surveys and service data  Incorporating private sector and public sector data  Improving survey methods by including measurements and biomarkers  Improving methods for small area assessment Strengthen Health Information Systems by  Supplementing vital registration systems  Combining census, surveys and service data  Incorporating private sector and public sector data  Improving survey methods by including measurements and biomarkers  Improving methods for small area assessment

Evidence and Information for Policy Acknowledgement Xu Ke Paul Kowal Saba Moussavi Nirmala Naidoo Amit Prasad Emese Verdes Xu Ke Paul Kowal Saba Moussavi Nirmala Naidoo Amit Prasad Emese Verdes